Sara Taylor

Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations

Pamela J. Goodwin, Marguerite Ennis, Kathleen I. Pritchard et al. · Journal of Clinical Oncology · 2011 · 199 citations

Whole-genome and transcriptome analysis enhances precision cancer treatment options

Erin Pleasance, Alexandra Böhm, Laura M. Williamson et al. · Annals of Oncology · 2022 · 107 citations · Full text

A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium

Sara Taylor, Stephen Chia, Susan Dent et al. · The Oncologist · 2010 · 67 citations · Full text

A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer

James Davidson, Ian Cromwell, Susan Ellard et al. · European Journal of Cancer · 2013 · 54 citations

Breast Oncology, Medicine, 21-Gene Recurrence Score® +8

A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer

Stephen Chia, Susan Ellard, Mihaela Mates et al. · Breast Cancer Research · 2017 · 35 citations · Full text